Fundraising FoxArrepath
3 known investors
Find your way into Arrepath
Sign up to see every warm intro you have to Arrepath
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arrepath team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ArrePath is a biotechnology company that applies AI/ML to drug discovery and development. The company leverages computational platforms and data science to accelerate the identification and advancement of new therapeutic candidates across multiple disease areas.
Founders & leadership
ZG
Zemer GitaiFounder and SAB Chair
KK
Kevin KrausePresident and Chief Executive Officer
Investors · 3
Innospark Ventures✓ confirmed by ArrepathBoston · $2M
How we know: the company's own site · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Insight Partners✓ confirmed by ArrepathNew York · $120M – $350M
How we know: the company's own site · Insight Partners's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Arrepath do?
- ArrePath is a biotechnology company that applies AI/ML to drug discovery and development. The company leverages computational platforms and data science to accelerate the identification and advancement of new therapeutic candidates across multiple disease areas.
- Who founded Arrepath?
- Arrepath was founded by Zemer Gitai.
- Who are Arrepath's investors?
- Arrepath's investors include Innospark Ventures, Insight Partners, Boehringer Ingelheim Venture Fund.